Reply: Understanding Subclass Diversity of Detectable β₁-Adrenergic Receptor Autoantibodies and their Clinical Impact

Free article

Comment

Yuji Nagatomo et al. J Am Coll Cardiol. 2017.

Free article

. 2017 Aug 8;70(6):809.

doi: 10.1016/j.jacc.2017.05.065.

No abstract available

Comment on

Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β₁-Adrenergic Receptors.
Nagatomo Y, McNamara DM, Alexis JD, Cooper LT, Dec GW, Pauly DF, Sheppard R, Starling RC, Tang WH; IMAC-2 Investigators. Nagatomo Y, et al. J Am Coll Cardiol. 2017 Feb 28;69(8):968-977. doi: 10.1016/j.jacc.2016.11.067. J Am Coll Cardiol. 2017. PMID: 28231950 Free PMC article. Clinical Trial.
β₁AAb Determined by Peptide ELISA: A Signal in the Noise?
Boege F, Westenfeld R, Jahns R. Boege F, et al. J Am Coll Cardiol. 2017 Aug 8;70(6):807-808. doi: 10.1016/j.jacc.2017.03.617. J Am Coll Cardiol. 2017. PMID: 28774387 No abstract available.
Autoantibodies Directed Against the β₁-Adrenergic Receptor in Patients With Dilated Cardiomyopathy.
Müller J, Wallukat G, Schimke I. Müller J, et al. J Am Coll Cardiol. 2017 Aug 8;70(6):808-809. doi: 10.1016/j.jacc.2017.04.068. J Am Coll Cardiol. 2017. PMID: 28774388 No abstract available.